CSBR
Champions Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.11
−3.22%Forward multiples
Based on analyst estimates
- P/E forward
- 46.45x
- P/E 2026E
- 50.50x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.06x
- Price / sales
- 1.20x
- Price / cash flow
- -15.90x
Enterprise value
- Enterprise value
- $71.0M
- EV / sales
- 1.19x
- EV / EBITDA
- 158.44x
- EV / EBIT
- -62.26x
- Market cap
- $71.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Apr 1, 2026